Fc receptors in antibody-dependent enhancement of viral infections (Q38615396)

4 September 2017

1 reference

22 August 2022

Fc receptors in antibody-dependent enhancement of viral infections (English)

1 reference

4 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Nicholas JC King

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

6

Suresh Mahalingam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1

Adam Taylor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Suan-Sin Foo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Luan Vu Dinh

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

1 November 2015

2 references

4 September 2017

22 August 2022

Immunological Reviews

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

22 August 2022

268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

340-364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

5 June 2020

cites work

1 reference

Occupancy and mechanism in antibody-mediated neutralization of animal viruses

21 January 2018

1 reference

A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus

21 January 2018

1 reference

The enhancement of virus infectivity by antibody

21 January 2018

1 reference

Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection

21 January 2018

1 reference

Complement receptor mediates enhanced flavivirus replication in macrophages

21 January 2018

1 reference

Antibody-dependent enhancement of Ebola virus infection

21 January 2018

1 reference

Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.

21 January 2018

1 reference

Arthritogenic alphaviruses: new insights into arthritis and bone pathology

21 January 2018

1 reference

Sindbis viruses and other alphaviruses as cause of human arthritic disease

21 January 2018

1 reference

Arthritogenic alphaviruses--an overview

21 January 2018

1 reference

Chikungunya: a re-emerging virus

21 January 2018

1 reference

The global distribution and burden of dengue

21 January 2018

1 reference

West Nile virus infection and immunity

21 January 2018

1 reference

West Nile virus: review of the literature

21 January 2018

1 reference

Antibody-dependent Plaque Enhancement: Its Antigenic Specificity in Relation to Togaviridae

21 January 2018

1 reference

Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis

21 January 2018

1 reference

Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus

21 January 2018

1 reference

Pro-inflammatory response resulting from sindbis virus infection of human macrophages: implications for the pathogenesis of viral arthritis

21 January 2018

1 reference

Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages

21 January 2018

1 reference

Persistent Ross River virus infection of murine macrophages: an in vitro model for the study of viral relapse and immune modulation during long-term infection

21 January 2018

1 reference

Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis

21 January 2018

1 reference

Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection.

21 January 2018

1 reference

Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus

21 January 2018

1 reference

Prime-boost immunization strategies against Chikungunya virus

21 January 2018

1 reference

Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice

21 January 2018

1 reference

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

21 January 2018

1 reference

Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses

21 January 2018

1 reference

Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002.

21 January 2018

1 reference

Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks

21 January 2018

1 reference

Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006

21 January 2018

1 reference

Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored

21 January 2018

1 reference

Maternal antibody and viral factors in the pathogenesis of dengue virus in infants

21 January 2018

1 reference

Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection

21 January 2018

1 reference

The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection

21 January 2018

1 reference

Monoclonal antibodies against the flavivirus West Nile

21 January 2018

1 reference

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

Avian Influenza in Hong Kong 1997–2002

21 January 2018

1 reference

Influenza: lessons from past pandemics, warnings from current incidents.

21 January 2018

1 reference

Human infection with a novel avian-origin influenza A (H7N9) virus

21 January 2018

1 reference

Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans

21 January 2018

1 reference

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

21 January 2018

1 reference

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

21 January 2018

1 reference

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

21 January 2018

1 reference

H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice

21 January 2018

1 reference

Host response to influenza virus: protection versus immunopathology

21 January 2018

1 reference

SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon

21 January 2018

1 reference

SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients

21 January 2018

1 reference

Multiple organ infection and the pathogenesis of SARS.

21 January 2018

1 reference

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

21 January 2018

1 reference

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

21 January 2018

1 reference

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.

21 January 2018

1 reference

Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway

21 January 2018

1 reference

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

21 January 2018

1 reference

Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus.

21 January 2018

1 reference

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes

21 January 2018

1 reference

A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies

21 January 2018

1 reference

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients

21 January 2018

1 reference

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry

21 January 2018

1 reference

Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals.

21 January 2018

1 reference

Neutralizing antibody response and SARS severity

21 January 2018

1 reference

Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome.

21 January 2018

1 reference

Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice

21 January 2018

1 reference

Infection enhancement of influenza A H1 subtype viruses in macrophage-like P388D1 cells by cross-reactive antibodies

21 January 2018

1 reference

Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry

21 January 2018

1 reference

New world bats harbor diverse influenza A viruses

21 January 2018

1 reference

Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody

21 January 2018

1 reference

Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications

21 January 2018

1 reference

Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine

21 January 2018

1 reference

Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.

21 January 2018

1 reference

Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk

21 January 2018

1 reference

The ferret as a model organism to study influenza A virus infection

21 January 2018

1 reference

Primary influenza A virus infection induces cross-reactive antibodies that enhance uptake of virus into Fc receptor-bearing cells

21 January 2018

1 reference

Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries

21 January 2018

1 reference

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada

21 January 2018

1 reference

Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial

21 January 2018

1 reference

Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease

21 January 2018

1 reference

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

21 January 2018

1 reference

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

21 January 2018

1 reference

In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera

21 January 2018

1 reference

Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines.

21 January 2018

1 reference

Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection

21 January 2018

1 reference

Immunopathogenesis of vaccine-enhanced RSV disease.

21 January 2018

1 reference

RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets

21 January 2018

1 reference

Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection

21 January 2018

1 reference

Vaccine-induced enhancement of viral infections.

21 January 2018

1 reference

Basic clinical and laboratory features of filoviral hemorrhagic fever

21 January 2018

1 reference

Infectivity-enhancing antibodies to Ebola virus glycoprotein

21 January 2018

1 reference

Epitopes required for antibody-dependent enhancement of Ebola virus infection

21 January 2018

1 reference

Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever

21 January 2018

1 reference

Infectious diseases. Ebola drug trials lurch ahead

21 January 2018

1 reference

Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine

21 January 2018

1 reference

Safety of recombinant VSV-Ebola virus vaccine vector in pigs

21 January 2018

1 reference

Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates

21 January 2018

1 reference

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

21 January 2018

1 reference

Antibody-Dependent Enhancement of Hepatitis C Virus Infection

21 January 2018

1 reference

Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro

21 January 2018

1 reference

Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection

21 January 2018

1 reference

Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera

21 January 2018

1 reference

Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis

21 January 2018

1 reference

Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation

21 January 2018

1 reference

Association of dengue virus NS1 protein with lipid rafts

21 January 2018

1 reference

Evaluation of a dengue NS1 antigen detection assay sensitivity and specificity for the diagnosis of acute dengue virus infection

21 January 2018

1 reference

Quasispecies theory and the behavior of RNA viruses

21 January 2018

1 reference

Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics

21 January 2018

1 reference

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

21 January 2018

1 reference

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

21 January 2018

1 reference

Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.

21 January 2018

1 reference

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity

21 January 2018

1 reference

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

21 January 2018

1 reference

Cross-reacting antibodies enhance dengue virus infection in humans

21 January 2018

1 reference

Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection

21 January 2018

1 reference

Immature Dengue Virus: A Veiled Pathogen?

21 January 2018

1 reference

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

21 January 2018

1 reference

Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM

21 January 2018

1 reference

Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody

21 January 2018

1 reference

Antibody-dependent enhancement of Marburg virus infection

21 January 2018

1 reference

Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization

21 January 2018

1 reference

Near-Atomic Resolution Cryo-Electron Microscopic Structure of Dengue Serotype 4 Virus

21 January 2018

1 reference

Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity

21 January 2018

1 reference

Neutralizing dengue antibody in pregnant Thai women and cord blood

21 January 2018

1 reference

Case report: vertical dengue infection

21 January 2018

1 reference

Dengue virus infection in early gestation with delivery of an unaffected fetus and no vertical transmission

21 January 2018

1 reference

Perinatal transmission of dengue: a report of 7 cases

21 January 2018

1 reference

Perinatal transmission of dengue: a case report

21 January 2018

1 reference

Clinical and Virological Features of Dengue in Vietnamese Infants

21 January 2018

1 reference

A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model

21 January 2018

1 reference

Dengue in Vietnamese Infants—Results of Infection‐Enhancement Assays Correlate with Age‐Related Disease Epidemiology, and Cellular Immune Responses Correlate with Disease Severity

21 January 2018

1 reference

Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.

21 January 2018

1 reference

First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies

21 January 2018

1 reference

Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease

21 January 2018

1 reference

Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells

21 January 2018

1 reference

The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability

21 January 2018

1 reference

Role of dendritic cells in antibody-dependent enhancement of dengue virus infection

21 January 2018

1 reference

Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection

21 January 2018

1 reference

Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection

21 January 2018

1 reference

Mouse model recapitulating human Fcγ receptor structural and functional diversity

21 January 2018

1 reference

Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity

21 January 2018

1 reference

The function of Fcγ receptors in dendritic cells and macrophages

21 January 2018

1 reference

The high-affinity human IgG receptor Fc gamma receptor I (FcγRI) is not associated with vascular leakage of dengue

21 January 2018

1 reference

Divergent intracellular sorting of Fc{gamma}RIIA and Fc{gamma}RIIB2.

21 January 2018

1 reference

Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cells.

21 January 2018

1 reference

Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection

21 January 2018

1 reference

Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-β in cultured hepatoma cells

21 January 2018

1 reference

Toll-like receptor 4 polymorphisms in dengue virus-infected children

21 January 2018

1 reference

Differential expression of Toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease

21 January 2018

1 reference

Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques

21 January 2018

1 reference

RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection

21 January 2018

1 reference

Cell type-specific involvement of RIG-I in antiviral response

21 January 2018

1 reference

Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse

21 January 2018

1 reference

Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion

21 January 2018

1 reference

Regulation of Toll-like receptor signaling pathways in innate immune responses

21 January 2018

1 reference

Immune signaling by RIG-I-like receptors

21 January 2018

1 reference

Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex

21 January 2018

1 reference

Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon interaction

21 January 2018

1 reference

CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages

21 January 2018

1 reference

Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus

21 January 2018

1 reference

CLEC5A is critical for dengue-virus-induced lethal disease

21 January 2018

1 reference

Gamma interferon (IFN-γ) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-α/β receptor-deficient mice

21 January 2018

1 reference

Cell type-specific mechanisms of interleukin-8 induction by dengue virus and differential response to drug treatment

21 January 2018

1 reference

Human TLR3 recognizes dengue virus and modulates viral replication in vitro

21 January 2018

1 reference

Induction of IFNα or IL-12 depends on differentiation of THP-1 cells in dengue infections without and with antibody enhancement

21 January 2018

1 reference

Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies

21 January 2018

1 reference

Downregulation of interferon-β in antibody-dependent enhancement of dengue viral infections of human macrophages is dependent on interleukin-6.

21 January 2018

1 reference

An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection.

21 January 2018

1 reference

Serum IL-10 as a marker of severe dengue infection

21 January 2018

1 reference

Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence.

21 January 2018

1 reference

A three-component biomarker panel for prediction of dengue hemorrhagic fever.

21 January 2018

1 reference

Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever.

21 January 2018

1 reference

Variable selection methods for developing a biomarker panel for prediction of dengue hemorrhagic fever

21 January 2018

1 reference

Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes

21 January 2018

1 reference

Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement.

21 January 2018

1 reference

Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions

21 January 2018

1 reference

Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program

21 January 2018

1 reference

Differential signal transduction, membrane trafficking, and immune effector functions mediated by FcgammaRI versus FcgammaRIIa

21 January 2018

1 reference

Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages

21 January 2018

1 reference

IgG opsonization of bacteria promotes Th17 responses via synergy between TLRs and FcγRIIa in human dendritic cells.

21 January 2018

1 reference

TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis

21 January 2018

1 reference

The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling

21 January 2018

1 reference

Elevated dengue virus nonstructural protein 1 serum levels and altered toll-like receptor 4 expression, nitric oxide, and tumor necrosis factor alpha production in dengue hemorrhagic Fever patients.

21 January 2018

1 reference

Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection

21 January 2018

1 reference

A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-γ in host resistance to infection

21 January 2018

1 reference

Nitric oxide activity in platelets of dengue haemorrhagic fever patients: the apparent paradoxical role of ADMA and l-NMMA.

21 January 2018

1 reference

Association Between Increased Vascular Nitric Oxide Bioavailability and Progression to Dengue Hemorrhagic Fever in Adults

21 January 2018

1 reference

Nitric oxide synthase expression correlates with death in an experimental mouse model of dengue with CNS involvement

21 January 2018

1 reference

Antiviral effect of nitric oxide during Japanese encephalitis virus infection

21 January 2018

1 reference

Induction of nitric oxide synthase during Japanese encephalitis virus infection: evidence of protective role

21 January 2018

1 reference

Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages.

21 January 2018

1 reference

Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3.

21 January 2018

1 reference

Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes.

21 January 2018

1 reference

Fcgamma receptors as regulators of immune responses

21 January 2018

1 reference

ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro

21 January 2018

1 reference

Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections

21 January 2018

1 reference

Cutting edge: TIGIT has T cell-intrinsic inhibitory functions

21 January 2018

1 reference

Down-regulation of mast cell responses through ITIM containing inhibitory receptors

21 January 2018

1 reference

FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

21 January 2018

1 reference

Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk

21 January 2018

1 reference

Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection

21 January 2018

1 reference

Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue

21 January 2018

1 reference

Promoter choice and translational repression determine cell type-specific cell surface density of the inhibitory receptor CD85j expressed on different hematopoietic lineages

21 January 2018

1 reference

Modulation of Toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infection

21 January 2018

1 reference

Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor

21 January 2018

1 reference

Collagen induces maturation of human monocyte-derived dendritic cells by signaling through osteoclast-associated receptor

21 January 2018

1 reference

The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection

21 January 2018

1 reference

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

21 January 2018

1 reference

Primary immunodeficiency disorders: antibody deficiency

21 January 2018

1 reference

The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders

21 January 2018

1 reference

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

21 January 2018

1 reference

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.

21 January 2018

1 reference

Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIb

21 January 2018

1 reference

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice

21 January 2018

1 reference

Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

21 January 2018

1 reference

West Nile virus neutralization by US plasma-derived immunoglobulin products

21 January 2018

1 reference

Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis

21 January 2018

1 reference

Therapeutic inflammatory monocyte modulation using immune-modifying microparticles

21 January 2018

1 reference

Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically

21 January 2018

1 reference

The clinical response of West Nile virus neuroinvasive disease to intravenous immunoglobulin therapy

21 January 2018

1 reference

21 January 2018

1 reference

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

21 January 2018

1 reference

Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia

21 January 2018

1 reference

Serious thrombocytopenia due to dengue hemorrhagic fever treated with high dosages of immunoglobulin

21 January 2018

1 reference

Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice

21 January 2018

1 reference

Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.

21 January 2018

1 reference

Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss

21 January 2018

1 reference

Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection

21 January 2018

1 reference

Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis

21 January 2018

1 reference

Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging

21 January 2018

1 reference

Chikungunya at the door--déjà vu all over again?

21 January 2018

1 reference

Case reports of neuro-Chikungunya in southern Thailand

21 January 2018

1 reference

Guillain-Barré Syndrome after Chikungunya Infection

21 January 2018

1 reference

The yin-yang of long pentraxin PTX3 in inflammation and immunity

21 January 2018

1 reference

Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps.

21 January 2018

1 reference

Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation.

21 January 2018

1 reference

Mechanism for Seasonal Vaccine Effect on Pandemic H1N1 Risk Remains Uncertain

21 January 2018

1 reference

C1qâ how many functions? How many receptors?

21 January 2018

1 reference

GSK3: an in-Toll-erant protein kinase?

21 January 2018

1 reference

New Insights in the Immunobiology of IL-1 Family Members

21 January 2018

1 reference

12 December 2020

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

1 reference

12 December 2020

Interaction of West Nile virus with primary murine macrophages: role of cell activation and receptors for antibody and complement

1 reference

12 December 2020

Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection.

1 reference

12 December 2020

Toll-like receptors and innate immunity

1 reference

12 December 2020

Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease

1 reference

12 December 2020

A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein

1 reference

12 December 2020

Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002.

1 reference

12 December 2020

Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?

1 reference

12 December 2020

ENHANCEMENT OF THE INFECTIVITY OF ARBOVIRUSES BY SPECIFIC ANTISERA PRODUCED IN DOMESTIC FOWLS

1 reference

12 December 2020

Longitudinal analysis of Severe Acute Respiratory Syndrome (SARS) coronavirus-specific antibody in SARS patients

1 reference

12 December 2020

1 reference

12 December 2020

Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses

1 reference

12 December 2020

Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin

1 reference

12 December 2020

Immunological enhancement of dengue virus replication.

1 reference

12 December 2020

Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release

1 reference

12 December 2020

Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection

1 reference

12 December 2020

Dengue haemorrhagic fever--a public health problem and a field for research

1 reference

12 December 2020

Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration of anti-D (Rh(0)-D) immune globulin

1 reference

12 December 2020

Comparison of P388D1 mouse macrophage cell line and human monocytes for assay of dengue-2 infection-enhancing antibodies

1 reference

12 December 2020

Chikungunya outbreak in Reunion: epidemiology and surveillance, 2005 to early January 2006.

1 reference

12 December 2020

Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages

1 reference

12 December 2020

Cross-Linking of CD32 Induces Maturation of Human Monocyte-Derived Dendritic Cells Via NF- B Signaling Pathway

1 reference

12 December 2020

Antibody-mediated enhancement of viral disease.

1 reference

12 December 2020

Identifiers

DOI

10.1111/IMR.12367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497532%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference